An Open-Label Randomized Trial Comparing Risperdal Consta With Oral Antipsychotic Care in the Treatment of Early Psychosis
Phase of Trial: Phase IV
Latest Information Update: 10 Dec 2013
At a glance
- Drugs Risperidone (Primary) ; Olanzapine; Quetiapine
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen Inc
- 10 Jun 2017 Biomarkers information updated
- 12 May 2009 Additional therapeutic area (PEC) identified as reported by ClinicalTrials.gov.
- 12 May 2009 Trial phase changed from III to IV as reported by ClinicalTrials.gov.